657 related articles for article (PubMed ID: 17115353)
21. Telephone assessment increases uptake of colonoscopy in a FOBT colorectal cancer-screening programme.
Rodger J; Steele RJ
J Med Screen; 2008; 15(2):105-7. PubMed ID: 18573779
[TBL] [Abstract][Full Text] [Related]
22. Colorectal cancer test use among persons aged > or = 50 years--United States, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Mar; 52(10):193-6. PubMed ID: 12653456
[TBL] [Abstract][Full Text] [Related]
23. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer screening: do we practice what we preach?
Colquhoun P; Weiss EG; Efron J; Nogueras JJ; Vernava AM; Wexner SD
Surg Innov; 2006 Jun; 13(2):81-5. PubMed ID: 17012147
[TBL] [Abstract][Full Text] [Related]
25. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
26. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
[TBL] [Abstract][Full Text] [Related]
27. What is the role of family in promoting faecal occult blood test screening? Exploring physician, average-risk individual, and family perceptions.
Lobchuk MM; Bapuji SB; McClement SE; Sisler JJ; Katz A; Martens P; Turner D; Clouston K
Cancer Epidemiol; 2012 Jun; 36(3):e190-9. PubMed ID: 22310235
[TBL] [Abstract][Full Text] [Related]
28. [Screening for colorectal cancer: what is the most effective strategy?].
Merzenich H; Giersiepen K; Kieschke J; Zeeb H
Gesundheitswesen; 2005 Nov; 67(11):803-8. PubMed ID: 16308813
[TBL] [Abstract][Full Text] [Related]
29. Bowel cancer screening--a role for general practice.
Foreman L
Aust Fam Physician; 2009 Apr; 38(4):200-3. PubMed ID: 19350068
[TBL] [Abstract][Full Text] [Related]
30. Colonoscopy is the preferred colorectal cancer screening method in a population-based program.
Marbet UA; Bauerfeind P; Brunner J; Dorta G; Valloton JJ; Delcò F
Endoscopy; 2008 Aug; 40(8):650-5. PubMed ID: 18609465
[TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer screening: physician recommendation is influential advice to Marylanders.
Gilbert A; Kanarek N
Prev Med; 2005 Aug; 41(2):367-79. PubMed ID: 15917034
[TBL] [Abstract][Full Text] [Related]
32. Better acceptance of Fecal Occult Blood Test (FOBT) for colorectal cancer screening during hospitalization.
Keller R; Schätzle A; Flieger D; Christl SU; Fischbach W
Z Gastroenterol; 2003 Jul; 41(7):655-8. PubMed ID: 12858236
[TBL] [Abstract][Full Text] [Related]
33. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
[TBL] [Abstract][Full Text] [Related]
34. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
Manus B; Brägelmann R; Armbrecht U; Stolte M; Stockbrügger RW
Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
[TBL] [Abstract][Full Text] [Related]
35. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
[TBL] [Abstract][Full Text] [Related]
36. Survey on colorectal cancer screening knowledge, attitudes, and practices of general practice physicians in Lazio, Italy.
Federici A; Giorgi Rossi P; Bartolozzi F; Farchi S; Borgia P; Guasticchi G
Prev Med; 2005 Jul; 41(1):30-5. PubMed ID: 15916990
[TBL] [Abstract][Full Text] [Related]
37. A population-based, community estimate of total colon examination: the impact on compliance with screening for colorectal cancer.
Schoen RE; Weissfeld JL; Trauth JM; Ling BS; Hayran M
Am J Gastroenterol; 2002 Feb; 97(2):446-51. PubMed ID: 11866286
[TBL] [Abstract][Full Text] [Related]
38. Increase in screening for colorectal cancer in older Americans: results from a national survey.
Chen X; White MC; Peipins LA; Seeff LC
J Am Geriatr Soc; 2008 Aug; 56(8):1511-6. PubMed ID: 18662217
[TBL] [Abstract][Full Text] [Related]
39. Colorectal cancer screening practise is influenced by ethnicity of medical practitioner and patient.
Koo JH; You MY; Liu K; Athureliya MD; Tang CW; Redmond DM; Connor SJ; Leong RW
J Gastroenterol Hepatol; 2012 Feb; 27(2):390-6. PubMed ID: 21793910
[TBL] [Abstract][Full Text] [Related]
40. Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms.
Dancourt V; Lejeune C; Lepage C; Gailliard MC; Meny B; Faivre J
Eur J Cancer; 2008 Oct; 44(15):2254-8. PubMed ID: 18760592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
